NDC 0713-0883

Evoxac

Cevimeline Hydrochloride

Evoxac is a Oral Capsule in the Human Prescription Drug category. It is labeled and distributed by Cosette Pharmaceuticals, Inc.. The primary component is Cevimeline Hydrochloride.

• Product ID: 0713-0883_e1f9f25e-98d3-e9e5-e053-2995a90ae380
• NDC: 0713-0883
• Product Type: Human Prescription Drug
• Proprietary Name: Evoxac
• Generic Name: Cevimeline Hydrochloride
• Dosage Form: Capsule
• Route of Administration: ORAL
• Marketing Start Date: 2022-06-15
• Marketing Category: NDA /
• Application Number: NDA020989
• Labeler Name: Cosette Pharmaceuticals, Inc.
• Substance Name: CEVIMELINE HYDROCHLORIDE
• Active Ingredient Strength: 30 mg/1
• Pharm Classes: Cholinergic Muscarinic Agonists [MoA], Cholinergic Receptor Agonist [EPC]
• NDC Exclude Flag: N
• Listing Certified Through: 2023-12-31

Packaging

NDC 0713-0883-01

100 CAPSULE in 1 BOTTLE, PLASTIC (0713-0883-01)

• Marketing Start Date: 2022-06-15
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details

NDC Crossover Matching brand name "Evoxac" or generic name "Cevimeline Hydrochloride"

NDC	Brand Name	Generic Name
0713-0883	Evoxac	cevimeline hydrochloride
63395-201	Evoxac	cevimeline hydrochloride
0054-0334	Cevimeline Hydrochloride	Cevimeline Hydrochloride
0713-0937	cevimeline hydrochloride	cevimeline hydrochloride
16571-657	Cevimeline Hydrochloride	Cevimeline Hydrochloride
40032-999	cevimeline hydrochloride	cevimeline hydrochloride
43386-999	cevimeline hydrochloride	cevimeline hydrochloride